Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Mikkilineni%2C+Lekha%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Mikkilineni%2C+Lekha%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Mikkilineni%2C+Lekha%22&type=Person&sort=year
PubPharm (16)
1
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas : results of a phase 1 trial
enthalten in:
Blood advances
| 2024
von
Brudno, J.
|
Natrakul, D.
|
Karrs, J.
| +11
CommentIn: Blood Adv. 2024 Feb 13;8(3):799-801. - PMID 38349671
Wird geladen...
2
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
enthalten in:
Molecular therapy : the journal of the American Society of Gene Therapy
| 2024
von
Mikkilineni, L.
|
Natrakul, D.
|
Lam, N.
| +22
Wird geladen...
3
Early and Late Toxicities of Chimeric Antigen Receptor T-Cells
enthalten in:
Hematology/oncology clinics of North America
| 2023
von
Epperly, R.
|
Giordani, V.
|
Mikkilineni, L.
| +1
Wird geladen...
4
Integrating Immune Therapies for the Treatment of Multiple Myeloma
enthalten in:
Journal of the National Comprehensive Cancer Network : JNCCN
| 2023
von
Mikkilineni, L.
|
Sidana, S.
Wird geladen...
5
The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
enthalten in:
Blood advances
| 2022
von
Faruqi, A.
|
Ligon, J.
|
Borgman, P.
| +12
Wird geladen...
6
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
enthalten in:
Blood advances
| 2021
von
Mikkilineni, L.
|
Yates, B.
|
Steinberg, S.
| +12
Wird geladen...
7
CAR T cell therapies for patients with multiple myeloma
enthalten in:
Nature reviews. Clinical oncology
| 2021
von
Mikkilineni, L.
|
Kochenderfer, J.
Wird geladen...
8
Author Correction : Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
enthalten in:
Nature medicine
| 2020
von
Brudno, J.
|
Lam, N.
|
Vanasse, D.
| +17
ErratumFor: Nat Med. 2020 Feb;26(2):270-280. - PMID 31959992
Wird geladen...
9
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
enthalten in:
Nature medicine
| 2020
von
Brudno, J.
|
Lam, N.
|
Vanasse, D.
| +17
CommentIn: Cancer Discov. 2020 Mar;10(3):338. - PMID 32005671
Wird geladen...
10
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses
enthalten in:
Journal for immunotherapy of cancer
| 2019
von
Zimmer, A.
|
Nichols, E.
|
Cimino-Mathews, A.
| +13
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
16
Aufsätze
16
E-Artikel
16
E-Ressourcen
Zeitschriftentitel
3
Blood advances
2
Journal for ImmunoTherapy of Cancer
2
Nature medicine
1
Blood
1
Frontiers in cell and developmental biology
1
Hematology/oncology clinics of North America
1
Journal for immunotherapy of cancer
1
Journal of clinical oncology : official journal...
1
Journal of the National Comprehensive Cancer Ne...
1
Molecular therapy : the journal of the American...
1
Nature reviews. Clinical oncology
1
Seminars in oncology
Alle anzeigen ...
weniger ...
Thema
14
Journal Article
7
Receptors, Chimeric Antigen
5
Research Support, N.I.H., Intramural
5
Review
4
Antigens, CD19
3
B-Cell Maturation Antigen
3
Clinical Trial, Phase I
3
Immune checkpoint inhibitor
3
Ovarian cancer
3
PARP inhibitor
3
Receptors, Antigen, T-Cell
3
Research Support, Non-U.S. Gov't
3
VEGF inhibition
2
Cytokines
2
Research Support, N.I.H., Extramural
2
glycolysis
2
oxidative phosphorylation
1
11056-06-7
1
28X28X9OKV
1
5V9KLZ54CY
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
9
2020-
7
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
16
Englisch
Haven't found what you're looking for?
Wird geladen...